Skip to main navigation Skip to search Skip to main content

MK-0677 (ibutamoren mesylate) for the treatment of patients recovering from hip fracture: A multicenter, randomized, placebo-controlled phase IIb study

  • Abraham Adunsky*
  • , Julie Chandler
  • , Norman Heyden
  • , Jeannine Lutkiewicz
  • , Boyd B. Scott
  • , Yuliya Berd
  • , Nancy Liu
  • , Dimitris A. Papanicolaou
    • *Corresponding author for this work
  • Sheba Medical Center at Tel Hashomer
  • Merck

Research output: Contribution to journal › Article › peer-review

59 Scopus citations

Fingerprint

Dive into the research topics of 'MK-0677 (ibutamoren mesylate) for the treatment of patients recovering from hip fracture: A multicenter, randomized, placebo-controlled phase IIb study'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Mathematics

Immunology and Microbiology